INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 192 filers reported holding INSMED INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,005 | +146.9% | 15 | 0.0% | 0.00% | – |
Q1 2024 | $407 | -12.5% | 15 | 0.0% | 0.00% | – |
Q4 2023 | $465 | +22.7% | 15 | 0.0% | 0.00% | – |
Q3 2023 | $379 | +19.6% | 15 | 0.0% | 0.00% | – |
Q2 2023 | $317 | -19.3% | 15 | -34.8% | 0.00% | – |
Q1 2023 | $393 | -14.6% | 23 | 0.0% | 0.00% | – |
Q4 2022 | $460 | – | 23 | +283.3% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 6 | -80.0% | 0.00% | – |
Q3 2021 | $1,000 | – | 30 | +275.0% | 0.00% | – |
Q1 2020 | $0 | – | 8 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 3,541,095 | $237,076,310 | 27.58% |
Sio Capital Management, LLC | 1,362,700 | $91,300,900 | 24.71% |
Palo Alto Investors LP | 2,138,963 | $143,310,521 | 16.61% |
Integral Health Asset Management, LLC | 1,550,000 | $103,850,000 | 9.87% |
Lion Point Capital, LP | 70,335 | $4,712,445 | 8.59% |
Octagon Capital Advisors LP | 650,216 | $43,564,472 | 6.85% |
MPM BioImpact LLC | 615,391 | $41,231,197 | 6.41% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,521,800 | $168,960,600 | 6.21% |
Eagle Health Investments LP | 513,700 | $34,417,900 | 6.04% |
Ikarian Capital, LLC | 5,070 | $33,969,000 | 5.92% |